Close Menu

Derek Lowe at In the Pipeline blogs about a recent post from Rob Carlson at Synthesis who recently toured a garage lab in the Silicon Valley. Carlson disclosed only vague details about the work that "biohackers" are doing in the garage; he only mentions that the participants are "screening for anti-cancer compounds," and includes two color photos depicting portions of an impressive-looking setup.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.